Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AryoSeven versus NovoSeven pharmacokinetic study in congenital factor VII deficiency
IRCT2016120231193N1Phase 3Completed
- Sponsor
- AryoGen Biopharma
- Start
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in congenital factor VII deficiency comparing AryoSeven first with NovoSeven first (2 arms). Started Jun 2017; status: completed.
02
Drugs
AryoSevencoagulation factor VIIa
03
Conditions
congenital factor VII deficiency
Beyond the preview
Go deeper on IRCT2016120231193N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016120231193N1.